Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 259

    1.

    The 'indirect' effects of cytomegalovirus infection.

    Freeman RB Jr.

    Am J Transplant. 2009 Nov;9(11):2453-8.PMID: 19843027 [PubMed - in process]Related articles

    2.

    Overcoming the ABO incompatibility barrier.

    Freeman RB Jr.

    Liver Transpl. 2009 Aug;15(8):831-3. No abstract available. PMID: 19642121 [PubMed - in process]Related articles

    3.

    ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation.

    Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D'Alessandro A, Pomfret EA, Freeman RB, Markmann JF, Hanto DW, Matas AJ, Roberts JP, Merion RM, Klintmalm GB; ASTS Standards on Organ Transplantation Committee.

    Am J Transplant. 2009 Sep;9(9):2004-11. Epub 2009 Jul 16.PMID: 19624569 [PubMed - in process]Related articles

    4.

    Stimulus for organ donation: a survey of the American Society of Transplant Surgeons membership.

    Rodrigue JR, Crist K, Roberts JP, Freeman RB Jr, Merion RM, Reed AI.

    Am J Transplant. 2009 Sep;9(9):2172-6. Epub 2009 Jul 16.PMID: 19624568 [PubMed - in process]Related articles

    5.

    The value of machine perfusion in deceased donor kidney transplantation.

    Cooper JT, Freeman RB.

    Am J Kidney Dis. 2009 Sep;54(3):410-2. Epub 2009 Jun 28. No abstract available. PMID: 19560851 [PubMed]Related articles

    6.

    Moving kidney allocation forward: the ASTS perspective.

    Freeman RB, Matas AT, Henry M, Segev DL, Kaufman DB, Roberts JP.

    Am J Transplant. 2009 Jul;9(7):1501-6. Epub 2009 Jun 10.PMID: 19519807 [PubMed - indexed for MEDLINE]Related articles

    7.

    Organ donation.

    Rhee J, Kern B, Cooper J, Freeman RB.

    Semin Liver Dis. 2009 Feb;29(1):19-39. Epub 2009 Feb 23. Review.PMID: 19235657 [PubMed - indexed for MEDLINE]Related articles

    8.

    Who should get a liver graft?

    Freeman RB, Jamieson N, Schaubel DE, Porte RJ, Villamil FG.

    J Hepatol. 2009 Apr;50(4):664-73. Epub 2009 Feb 12. No abstract available. PMID: 19233503 [PubMed - indexed for MEDLINE]Related articles

    9.

    Transplantation risks and the real world: what does 'high risk' really mean?

    Freeman RB, Cohen JT.

    Am J Transplant. 2009 Jan;9(1):23-30. Epub 2008 Nov 27. Review.PMID: 19067660 [PubMed - indexed for MEDLINE]Related articles

    10.

    SOFT endpoints in liver transplantation.

    Freeman RB Jr.

    Am J Transplant. 2008 Dec;8(12):2483-4. No abstract available. PMID: 19032217 [PubMed - indexed for MEDLINE]Related articles

    11.

    Report of the Paris consensus meeting on expanded criteria donors in liver transplantation.

    Durand F, Renz JF, Alkofer B, Burra P, Clavien PA, Porte RJ, Freeman RB, Belghiti J.

    Liver Transpl. 2008 Dec;14(12):1694-707. Review.PMID: 19025925 [PubMed - indexed for MEDLINE]Related articles

    12.

    Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation.

    Ho KJ, Owens CD, Johnson SR, Khwaja K, Curry MP, Pavlakis M, Mandelbrot D, Pomposelli JJ, Shah SA, Saidi RF, Ko DS, Malek S, Belcher J, Hull D, Tullius SG, Freeman RB, Pomfret EA, Whiting JF, Hanto DW, Karp SJ.

    Transplantation. 2008 Jun 15;85(11):1588-94.PMID: 18551064 [PubMed - indexed for MEDLINE]Related articles

    13.

    Liver and intestine transplantation in the United States, 1997-2006.

    Freeman RB Jr, Steffick DE, Guidinger MK, Farmer DG, Berg CL, Merion RM.

    Am J Transplant. 2008 Apr;8(4 Pt 2):958-76.PMID: 18336699 [PubMed - indexed for MEDLINE]Related articles

    14.

    Liver transplantation for hepatocellular carcinoma: racial disparities?

    Freeman RB.

    Am J Gastroenterol. 2008 Jan;103(1):128-30.PMID: 18184120 [PubMed - indexed for MEDLINE]Related articles

    15.

    "Transplant tourism" in the United States?

    Freeman RB.

    Transplantation. 2007 Dec 27;84(12):1559-60. No abstract available. PMID: 18165763 [PubMed - indexed for MEDLINE]Related articles

    16.

    Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card.

    Freeman RB Jr.

    Hepatology. 2008 Mar;47(3):1052-7. Review. No abstract available. PMID: 18161047 [PubMed - indexed for MEDLINE]Related articles

    17.

    Predicting the future?

    Freeman RB Jr.

    Liver Transpl. 2007 Nov;13(11):1503-5. No abstract available. PMID: 17969196 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.
    19.

    Justice, administrative law, and the transplant clinician: the ethical and legislative basis of a national policy on donor liver allocation.

    Barshes NR, Hacker CS, Freeman RB Jr, Vierling JM, Goss JA.

    J Contemp Health Law Policy. 2007 Spring;23(2):200-30. No abstract available. PMID: 17642381 [PubMed - indexed for MEDLINE]Related articles

    20.

    The model for end-stage liver disease comes of age.

    Freeman RB Jr.

    Clin Liver Dis. 2007 May;11(2):249-63. Review.PMID: 17606205 [PubMed - indexed for MEDLINE]Related articles

    21.

    Survival benefit: quality versus quantity and trade-offs in developing new renal allocation systems.

    Freeman RB Jr.

    Am J Transplant. 2007 May;7(5):1043-6. Epub 2007 Mar 12. No abstract available. PMID: 17359499 [PubMed - indexed for MEDLINE]Related articles

    22.

    Fetal cells participate over time in the response to specific types of murine maternal hepatic injury.

    Khosrotehrani K, Reyes RR, Johnson KL, Freeman RB, Salomon RN, Peter I, Stroh H, Guégan S, Bianchi DW.

    Hum Reprod. 2007 Mar;22(3):654-61. Epub 2006 Oct 30.PMID: 17074776 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Transplantation for hepatocellular carcinoma: The Milan criteria and beyond.

    Freeman RB Jr.

    Liver Transpl. 2006 Nov;12(11 Suppl 2):S8-13. Review.PMID: 17051567 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database.

    Freeman RB, Mithoefer A, Ruthazer R, Nguyen K, Schore A, Harper A, Edwards E.

    Liver Transpl. 2006 Oct;12(10):1504-11.PMID: 16952174 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    It is time to re-think 'extended criteria'.

    Freeman RB, Klintmalm GB.

    Am J Transplant. 2006 Oct;6(10):2225-7. Epub 2006 Aug 21. No abstract available. PMID: 16925564 [PubMed - indexed for MEDLINE]Related articles

    26.

    Utility is not just posttransplant outcome!

    Freeman RB Jr.

    Am J Transplant. 2006 Nov;6(11):2817. Epub 2006 Jun 22. No abstract available. PMID: 16796713 [PubMed - indexed for MEDLINE]Related articles

    27.

    Waiting list removal rates among patients with chronic and malignant liver diseases.

    Freeman RB, Edwards EB, Harper AM.

    Am J Transplant. 2006 Jun;6(6):1416-21.PMID: 16686765 [PubMed - indexed for MEDLINE]Related articles

    28.

    Liver allocation: the intent-to-treat approach.

    Freeman RB.

    Transpl Int. 2006 Apr;19(4):270-4. No abstract available. PMID: 16573541 [PubMed - indexed for MEDLINE]Related articles

    29.

    Mortality risk, behavior, and pediatric liver allocation.

    Freeman RB Jr.

    Liver Transpl. 2006 Jan;12(1):12-5. No abstract available. Erratum in: Liver Transpl. 2006 Apr;12(4):694. PMID: 16382452 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Regional variations in peer reviewed liver allocation under the MELD system.

    Rodriguez-Luna H, Vargas HE, Moss A, Reddy KS, Freeman RB, Mulligan D.

    Am J Transplant. 2005 Sep;5(9):2244-7.PMID: 16095504 [PubMed - indexed for MEDLINE]Related articles

    31.

    Excellent liver transplant survival rates under the MELD/PELD system.

    Freeman RB, Harper A, Edwards EB.

    Transplant Proc. 2005 Mar;37(2):585-8.PMID: 15848465 [PubMed - indexed for MEDLINE]Related articles

    32.

    MELD and the quality of life.

    Freeman RB.

    Liver Transpl. 2005 Feb;11(2):134-6. No abstract available. PMID: 15666383 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    The survival benefit of liver transplantation.

    Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA.

    Am J Transplant. 2005 Feb;5(2):307-13.PMID: 15643990 [PubMed - indexed for MEDLINE]Related articles

    34.

    MELD: the holy grail of organ allocation?

    Freeman RB.

    J Hepatol. 2005 Jan;42(1):16-20. No abstract available. PMID: 15629501 [PubMed - indexed for MEDLINE]Related articles

    35.

    Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients.

    Freeman RB, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Heaton N; Valganciclovir Solid Organ Transplant Study Group.

    Transplantation. 2004 Dec 27;78(12):1765-73.PMID: 15614149 [PubMed - indexed for MEDLINE]Related articles

    36.

    Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis.

    Amin MG, Wolf MP, TenBrook JA Jr, Freeman RB Jr, Cheng SJ, Pratt DS, Wong JB.

    Liver Transpl. 2004 Dec;10(12):1468-75.PMID: 15558599 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy.

    Wiesner RH, Freeman RB, Mulligan DC.

    Gastroenterology. 2004 Nov;127(5 Suppl 1):S261-7. Review.PMID: 15508092 [PubMed - indexed for MEDLINE]Related articles

    38.

    Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients.

    Merion RM, Rush SH, Dykstra DM, Goodrich N, Freeman RB Jr, Wolfe RA.

    Am J Transplant. 2004 Nov;4(11):1792-7.PMID: 15476478 [PubMed - indexed for MEDLINE]Related articles

    39.

    Mathematical models and behavior: assessing delta MELD for liver allocation.

    Freeman RB.

    Am J Transplant. 2004 Nov;4(11):1735-6. No abstract available. PMID: 15476468 [PubMed - indexed for MEDLINE]Related articles

    40.

    Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA.

    Olthoff KM, Brown RS Jr, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, Millis JM, Roberts JP, Shaked A, Wiesner RH, Lucey MR.

    Liver Transpl. 2004 Oct;10(10 Suppl 2):A6-22.PMID: 15382225 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection.

    Freeman RB.

    Liver Transpl. 2004 Oct;10(10 Suppl 2):S2-3. No abstract available. PMID: 15382218 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    MELD and liver allocation: continuous quality improvement.

    Freeman RB Jr.

    Hepatology. 2004 Oct;40(4):787-9. Review. No abstract available. PMID: 15382164 [PubMed - indexed for MEDLINE]Related articles

    43.

    Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised host.

    Freeman RB.

    Expert Opin Pharmacother. 2004 Sep;5(9):2007-16. Review.PMID: 15330737 [PubMed - indexed for MEDLINE]Related articles

    44.

    Improving liver allocation: MELD and PELD.

    Freeman RB Jr, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM.

    Am J Transplant. 2004;4 Suppl 9:114-31. Review.PMID: 15113360 [PubMed - indexed for MEDLINE]Related articles

    45.

    Mortality risk versus other endpoints: who should come first on the liver transplant waiting list?

    Freeman RB.

    Liver Transpl. 2004 May;10(5):675-7. No abstract available. PMID: 15108260 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Cytokine gene promoter polymorphisms and mortality in acute renal failure.

    Jaber BL, Rao M, Guo D, Balakrishnan VS, Perianayagam MC, Freeman RB, Pereira BJ.

    Cytokine. 2004 Mar 7;25(5):212-9.PMID: 15036247 [PubMed - indexed for MEDLINE]Related articles

    47.

    Aerobic capacity is associated with 100-day outcome after hepatic transplantation.

    Epstein SK, Freeman RB, Khayat A, Unterborn JN, Pratt DS, Kaplan MM.

    Liver Transpl. 2004 Mar;10(3):418-24.PMID: 15004771 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.

    Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, Wiesner RH.

    Hepatology. 2004 Mar;39(3):764-9.PMID: 14999695 [PubMed - indexed for MEDLINE]Related articles

    49.

    Liver allocation for HCC: a moving target.

    Freeman RB.

    Liver Transpl. 2004 Jan;10(1):49-51. No abstract available. PMID: 14755777 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Results of the first year of the new liver allocation plan.

    Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R; United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee.

    Liver Transpl. 2004 Jan;10(1):7-15.PMID: 14755772 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...